Tag: Lotus

March 21, 2019 Off

Alvogen’s Taiwan company – Lotus – exchange stake with Fuji Pharma

@alvogenpr subsidiary in Taiwan, Lotus Pharmaceuticals today announced capital and business collaboration agreements with Fuji Pharma in Japan, as Fuji has acquired a 2.0% stake in Lotus for approximately US$20 million (or NT$ 617 million, JPY 2.2 billion). Lotus has also acquired 3.9% stake in Fuji for an equal sum.

December 13, 2018 Off

Lotus Pharmaceuticals welcomes Alvogen’s CEO as its new Chairman

By Dino Mustafić

Alvogen’s Chairman & CEO Robert Wessman is the new Chairman of the Board at the publicly listed Lotus Pharmaceuticals in Taiwan, succeeding Andrew Lin. Lotus Pharmaceuticals, which is majority-owned by Alvogen, has been under the leadership and guidance of Lin since 2016.